News Focus
News Focus
Followers 24
Posts 2706
Boards Moderated 0
Alias Born 10/23/2003

Re: None

Friday, 01/06/2023 6:07:56 PM

Friday, January 06, 2023 6:07:56 PM

Post# of 9090
Revance Announces U.S. FDA Acceptance of Supplemental Biologics License Application (sBLA) for DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia

They wait until Friday after hours? Must think it’s bad news
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y